Trials / Completed
CompletedNCT03761160
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy: A Randomize Pilot Trial in Men Newly Treated With Androgen Deprivation Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- Male
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This research study seeks to develop and evaluate a mobile health app which aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habits.
Detailed description
This research study seeks to develop and evaluate a mobile health app which aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habits. The first phase of the research study seeks to evaluate the experience of the first version of the mobile health app within a group of participants and what they think of it. The investigators are interested in how individuals react to the use of a developed mobile health app and what they think of it.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mobile Health App | mobile health app aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habit |
| OTHER | Usual care | Usual care per hospital guidelines |
Timeline
- Start date
- 2019-07-16
- Primary completion
- 2020-01-28
- Completion
- 2020-07-10
- First posted
- 2018-12-03
- Last updated
- 2023-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03761160. Inclusion in this directory is not an endorsement.